Chemistry: molecular biology and microbiology – Process of mutation – cell fusion – or genetic modification – Introduction of a polynucleotide molecule into or...
Reexamination Certificate
2006-03-14
2006-03-14
Guzo, David (Department: 1633)
Chemistry: molecular biology and microbiology
Process of mutation, cell fusion, or genetic modification
Introduction of a polynucleotide molecule into or...
C435S456000, C435S320100, C435S325000, C435S366000, C435S370000, C424S093200, C424S093600
Reexamination Certificate
active
07011976
ABSTRACT:
Replication competent adenoviral vectors specific for cells expressing alfa-fetoprotein (AFP) are provided. These replication-competetent adenoviral vectors comprise adenovirus genes essential for replication under the transcriptional control of an AFP-transcriptional regulatory element.
REFERENCES:
patent: 5302698 (1994-04-01), Morinaga et al.
patent: 5328470 (1994-07-01), Nabel et al.
patent: 5354674 (1994-10-01), Hodgson
patent: 5501662 (1996-03-01), Hofmann
patent: 5635383 (1997-06-01), Wu et al.
patent: 5648478 (1997-07-01), Henderson
patent: 5698443 (1997-12-01), Henderson et al.
patent: 5804407 (1998-09-01), Tamaoki et al.
patent: 5807738 (1998-09-01), Tamaoki et al.
patent: 5827686 (1998-10-01), Tamaoki et al.
patent: 5998205 (1999-12-01), Hallenbeck et al.
patent: 6254862 (2001-07-01), Little et al.
patent: 2134994 (1995-05-01), None
patent: 0 415 731 (1991-03-01), None
patent: WO 93/19768 (1993-10-01), None
patent: WO 94/26915 (1994-11-01), None
patent: WO 95/00655 (1995-01-01), None
patent: WO 95/11984 (1995-05-01), None
patent: WO 96/17053 (1996-06-01), None
patent: WO 96/21036 (1996-07-01), None
patent: WO 96/21036 (1996-07-01), None
patent: WO 96/34969 (1996-11-01), None
patent: WO 97/01358 (1997-01-01), None
patent: WO 98/35028 (1998-08-01), None
Arbuthnot et al., “In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector”Human Gene Ther.7:1503-1514 (1996).
Arnberg et al., “Fiber genes of adenoviruses with tropism for the eye and the genital tract”Virol.227:239-244 (1997).
Bailey et al., “Cell type specific regulation of expression from the Ad40 E1B promoter in recombinant Ad5/Ad40 viruses”Virology202:695-706 (1994).
Bailey et al., “Enteric adenovirus type 40: Expression of E1B proteins in vitro and in vivo”Virology193:631-641 (1993).
Behringer et al., “Dwarf mice produced by genetic ablation of growth hormone-expressing cells”Genes Dev.2:453-461 (1988).
Berkner and Sharp, “Generation of adenovirus by transfection of plasmids”Nucl. Acids Res.11(17):6003-6020 (1983).
Bett et al., “An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3”Proc. Natl. Acad. Sci USA91:8802-8806 (1994).
Bett et al., “Packaging capacity and stability of human adenovirus type 5 vectors”J. Virology67(10):5911-5921 (1993).
Bischoff et al., “An adenovirus mutant that replicates selectively in p53-deficient human tumor cells,”Science274(5286):373-376 (1996).
Braun et al. “Immunogenic duplex nucleic acids are nuclease resistant”J. Immunol.141(6):2084-1089 (1988).
Bridge et al., “Redundant control of adenovirus late gene expression by early region 4”J. Virol.63(2):631-638 (1989).
Chang et al., “Cancer Gene Therapy Using novel tumor specific replication competent adenoviral vectors” Cold Spring Harbor Gene Therapy Meeting, p. 53 (1996).
Chaturvedi et al., “Stabilization of triple-stranded oligonucleotide complexes: use of probes containing alternating phosphodiester and stereo-uniform cationic phosphoramidate linkages”Nucleic Acids Res.24(12):2318-2323 (1996).
Current Protocols in Molecular Biology(Ausubel et al., eds., 1987) Supp. 30, Section 7.7.18-19, Table 7.7.1.
Emerson et al., “The zonal expression of alpha-fetoprotein transgenes in the livers of adult mice”Devel. Dynamics195:55-65 (1992).
Felgner and Ringold, “Cationic liposome-mediated tranfection”Nature337:387-388 (1989).
Flint “Expression of adenoviral genetic information in productively infected cells”Biochem. Biophys. Acta651:175-208 (1982).
Flint “Regulation of adenovirus mRNA formation”Advances Virus Research31:169-228 (1986).
Frankel et al., “Selection and characterization of ricin toxin A-chain mutations inSaccharomyces cerevisiae” Mol. Cell. Biol.9(2):415-420 (1989).
Ghebranious et al., “Developmental control of transcription of the cat reporter gene by a truncated mouse alphafetoprotein gene regulatory region in transgenic mice”Mo. Reprod. Devel.42:1-6 (1995).
Graham et al., “A new technique for the assay of infectivity of human adenovirus 5 DNA”Virology52:456-467 (1973).
Graham et al. “Characteristics of a human cell line transformed by DNA from human adenovirus type 5”J. Gen. Virol.36:59-72 (1977).
Graham, “Covalently closed circles of human adenovirus DNA are infectious”EMBO Journal3(12):2917-2922 (1984).
Graham, “Growth of 293 cells in suspension culture”J. Genetic Virology68:937-940 (1987).
Grand, “The structure and functions of the adenovirus early region 1 proteins”Biochem. J.241-25-38 (1987).
Groupp et al. “Characterization of the distal alpha-fetoprotein enhancer, a strong, long distance, liver specific activator”J. Biol. Chem.269(35):22178-22187 (1994).
Hallenbeck, O. et al., “Novel Tumor Specific Replication Competent Adenoviral Vectors for Gene Therapy of Cancer”Cancer Gene Therapy,3(6):S19-S20 (1996).
Hayashi et al., “Expression of a thyroid hormone-responsive recombinant gene introduced into adult mice livers by replication-defective adenovirus can be regulated by endogenous thyroid hormone receptor”J. Biol. Chem.269(39):23872-23875 (1994).
Huber et al., “VDEPT: An enzyme/prodrug gene therapy approach for the treatment of metastic colorectal cancer”Adv. Drug Delivery Rev.17:279-292 (1995).
Ido et al., “Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter”Cancer Res.55(14):3105-1309 (1995).
Jaffe et al., “Adenovirus-mediated in vivo gene transfer and expression in normal rat liver”Nat. Genet.1:372-378 (1992).
Kanai et al., “Adenovirally directed enzyme prodrug therapy again hepatocellular carcinoma”Hepatology22(4 Part 2):188A Abstract No. 328 (1995).
Kanai et al., “Gene therapy for hepatocellular carcinom: Chemosensitivity conferred by adenovirus-mediated transfer of the suicide gene”Gastroenterol.110(4):A1227 Suppl. (1996).
Kanai et al., “Gene Therapy for an alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene”Hepatology23(6):1359-1368 (1996).
Kanai et al., “Prolonged survival of mice bearing disseminated gastric cancer by adenovirus-mediated gene therapy”Cancer Gene Ther.3(6):S32 Abstract No. P-82 (1996).
Kaneko et al., “Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression”Cancer Res.5:5283-5287 (1995).
Kaneko et al., “Gene therapy of hepatocellular carcinoma using the alpha-fetoprotein in an adenoviral vector”Hepatology22(4 Part 2):158A Abstract No. 206 (1995).
Katsuragi et al., “A case of gall bladder cancer with high level alpha-fetoprotein”Japan J. Clin. Radiol.34:371-374 (1989).
Kawamoto et al., “Alpha-fetoprotein-producing pancreatic cancer—A case report and review of 28 cases”Hepato-Gastroentrol.39:282-286 (1992).
Koyama et al., “Biochemical characterization of alpha-fetoprotein and other serum proteins produced by a uterine-endometrial adenocarcinoma”Jpn. J. Cancer Res.87:612-617 (1996).
Lamb et al., “Nucleotide sequence of cloned cDNA coding for preproricin”Eur. J. Biochem.148:265-270 (1985).
Latimer et al., “Specificity of monoclonal antibodies produced against phosphorothioate and ribo modified DNAs”Mol. Immunol.32(14/15):1057-1064 (1995).
Le Gal Le Salle et al., “An adenovirus vector for gene transfer into neurons and glia in the brain”Science259:988-990 (1993).
Mastrangeli et al., “Diversity of airway epithelial cell targets for in vivo recombinatn adenovirus-
Henderson Daniel R.
Lamparski Henry G.
Little Andrew S.
Schuur Eric R.
Burkhart Michael D.
Calydon, Inc.
DLA Piper Rudnick Gray Cary US LLP
Guzo David
LandOfFree
Adenovirus vectors specific for cells expressing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adenovirus vectors specific for cells expressing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adenovirus vectors specific for cells expressing... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3530207